Compare CKX & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CKX | DRIO |
|---|---|---|
| Founded | 1930 | 2011 |
| Country | United States | United States |
| Employees | N/A | 165 |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 18.5M |
| IPO Year | 1996 | 2013 |
| Metric | CKX | DRIO |
|---|---|---|
| Price | $15.86 | $1.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $8.20 |
| AVG Volume (30 Days) | ★ 476.1K | 75.8K |
| Earning Date | 11-24-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1125.00 | ★ 1559.02 |
| EPS | 0.09 | ★ 2.46 |
| Revenue | $838,543.00 | ★ $7,394,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $33.65 |
| P/E Ratio | $178.06 | ★ $0.67 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $8.66 | $1.45 |
| 52 Week High | $24.74 | $14.77 |
| Indicator | CKX | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 70.02 | 18.24 |
| Support Level | $10.04 | N/A |
| Resistance Level | N/A | $8.01 |
| Average True Range (ATR) | 1.44 | 0.47 |
| MACD | 0.62 | -0.07 |
| Stochastic Oscillator | 37.93 | 0.00 |
CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way, and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. It has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Timber segment.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.